Fractyl Health Stock Forecast
NASDAQ: GUTSHealth CareMedical/Dental InstrumentsUSD
Market open · Delayed 15 min · as of Oct 9, 11:13 AM ET
GUTS analyst consensus
Consensus (7 analysts)
strong_buy
Avg. price target
$60.40+1321.18%
- Strong buy 0
- Buy 6
- Hold 1
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 7 Wall Street analysts covering Fractyl Health (2026-10-09), 6 rate the stock a buy or strong buy, 1 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "strong_buy". The average 12-month price target is $60.40, with a high estimate of $96.00 and a low estimate of $24.00. The average target implies upside of 1321.2% from the current price of $4.25.
The spread between the highest and lowest targets is 300.0%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for GUTS.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 0 | 0% |
| Buy | 6 | 86% |
| Hold | 1 | 14% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-09.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $24.00 | +464.71% |
| Average target | $60.40 | +1321.18% |
| High target | $96.00 | +2158.82% |